Welcome to the future of Medicine

3V Medical Research Group has developed a product Luxsol^® Suspension Solution, as a targeted therapeutic therapy to treat Covid-19 and Influenza.

The COVID-19 Pandemic has dominated our lives. Pandemic’s that desperately need treatments. 3V Medical Research Group is committed to treat COVID-19 for everyone without undesirable side effects. There are 25% of the USA population not willing to receive the vaccine at the risk of being infected with COVID-19 virus.

Our Mission

Treatment

Treating Covid-19 and Influenza Safely and effectively is 3V Medical Research Group’s goal.

Development

Developing medical products for the present and future.

Science

Our technology leverages the ability of small molecular weight substances to directly treat as a targeted therapeutic therapy.

Committment

3VM is committed to developing products that focus on safety, while still providing meaningful efficacy.

Patents and Trademarks

3V Medical Research Group, Inc. has 55 US and Worldwide patents approved or pending. 9 registered 4 pending US and Worldwide trademarks.